Loading
A phase 2 trial of Intraoperative radiotherapy in Breast cancer, run by Gangnam Severance Hospital, with a status the registry has not verified recently.
Intraoperative Radiotherapy for Korean Patients With Breast Cancer is a phase 2 interventional study registered as NCT02213991 by Gangnam Severance Hospital, with 215 participants planned, started 2014-08 and due to reach its primary completion in 2017-10. Interventions recorded: Intraoperative radiotherapy using Intrabeam®. Conditions recorded: Breast Cancer.
Linked to the technology Intraoperative radiotherapy because the registry names it ("intraoperative radiotherapy") among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Intraoperative radiotherapy (IORT), Breast cancer (all types) and the tag pipeline.
Shares Intraoperative radiotherapy (IORT) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/